Targeting CCR5: A central approach to HIV treatment and cure strategies
Abstract
No abstract availableKeywords
Funding Information
- Yale School of Medicine
This publication has 112 references indexed in Scilit:
- Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cureClinical Immunology, 2023
- Structural basis for Cas9 off-target activityCell, 2022
- HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure StrategiesCurrent HIV/AIDS Reports, 2022
- Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applicationsBiomaterials, 2020
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in AdultsJAMA, 2016
- Modeling the allosteric modulation of CCR5 function by MaravirocDrug Discovery Today: Technologies, 2013
- Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancerJournal of Surgical Oncology, 2008
- A Phase II Randomized Study of HIV-Specific T-Cell Gene Therapy in Subjects with Undetectable Plasma Viremia on Combination Antiretroviral TherapyMolecular Therapy, 2002
- Chemokines and Their Receptors in the Central Nervous SystemFrontiers in Neuroendocrinology, 2001
- Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120European Journal of Immunology, 1998